Ekadharma International Tbk
PT Ekadharma International Tbk, together with its subsidiaries, engages in manufacturing and sale of self adhesive tapes and related supplementary materials in Indonesia and Malaysia. It operates through Sticking Plaster and Others segments. The company offers lint roller, accessories, industrial tape, packaging products, and cutters; cloth tape/masking tape products; reflective, PVC electrical, … Read more
Ekadharma International Tbk (EKAD) - Net Assets
Latest net assets as of September 2025: Rp1.21 Trillion IDR
Based on the latest financial reports, Ekadharma International Tbk (EKAD) has net assets worth Rp1.21 Trillion IDR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp1.31 Trillion) and total liabilities (Rp97.02 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rp1.21 Trillion |
| % of Total Assets | 92.57% |
| Annual Growth Rate | 14.7% |
| 5-Year Change | 25.13% |
| 10-Year Change | 308.18% |
| Growth Volatility | 20.58 |
Ekadharma International Tbk - Net Assets Trend (2000–2024)
This chart illustrates how Ekadharma International Tbk's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ekadharma International Tbk (2000–2024)
The table below shows the annual net assets of Ekadharma International Tbk from 2000 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Rp1.19 Trillion | +3.83% |
| 2023-12-31 | Rp1.15 Trillion | +3.14% |
| 2022-12-31 | Rp1.11 Trillion | +8.00% |
| 2021-12-31 | Rp1.03 Trillion | +8.19% |
| 2020-12-31 | Rp952.36 Billion | +11.71% |
| 2019-12-31 | Rp852.54 Billion | +17.66% |
| 2018-12-31 | Rp724.58 Billion | +9.32% |
| 2017-12-31 | Rp662.82 Billion | +11.96% |
| 2016-12-31 | Rp592.00 Billion | +102.77% |
| 2015-12-31 | Rp291.96 Billion | +8.98% |
| 2014-12-31 | Rp267.91 Billion | +12.70% |
| 2013-12-31 | Rp237.71 Billion | +23.82% |
| 2012-12-31 | Rp191.98 Billion | +30.03% |
| 2011-12-31 | Rp147.65 Billion | +17.93% |
| 2010-12-31 | Rp125.20 Billion | +40.81% |
| 2009-12-31 | Rp88.91 Billion | +11.28% |
| 2008-12-31 | Rp79.90 Billion | +31.21% |
| 2007-12-31 | Rp60.90 Billion | +5.11% |
| 2006-12-31 | Rp57.94 Billion | +5.71% |
| 2005-12-31 | Rp54.81 Billion | +2.38% |
| 2004-12-31 | Rp53.53 Billion | +7.52% |
| 2003-12-31 | Rp49.79 Billion | +2.22% |
| 2002-12-31 | Rp48.71 Billion | +3.91% |
| 2001-12-31 | Rp46.87 Billion | +5.80% |
| 2000-12-31 | Rp44.30 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ekadharma International Tbk's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4274.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rp763.54 Billion | 65.88% |
| Common Stock | Rp34.94 Billion | 3.01% |
| Other Comprehensive Income | Rp360.45 Billion | 31.10% |
| Other Components | Rp138.49 Million | 0.01% |
| Total Equity | Rp1.16 Trillion | 100.00% |
Ekadharma International Tbk Competitors by Market Cap
The table below lists competitors of Ekadharma International Tbk ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Study King Co., Ltd.
TWO:6780
|
$6.90 Million |
|
FACT II Acquisition Corp. Warrant
NASDAQ:FACTW
|
$6.90 Million |
|
Huddlestock Fintech As
OL:HUDL
|
$6.90 Million |
|
PT Central Proteina Prima Tbk
STU:4PT
|
$6.90 Million |
|
Osia Hyper Retail Limited
NSE:OSIAHYPER
|
$6.89 Million |
|
IO Biotech Inc
NASDAQ:IOBT
|
$6.89 Million |
|
Tamtron Group Oyj
HE:TAMTRON
|
$6.89 Million |
|
K-Tech Solutions Company Limited Class A Ordinary Shares
NASDAQ:KMRK
|
$6.89 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ekadharma International Tbk's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,114,234,230,000 to 1,159,074,823,000, a change of 44,840,593,000 (4.0%).
- Net income of 64,435,010,000 contributed positively to equity growth.
- Dividend payments of 31,330,654,000 reduced retained earnings.
- Other comprehensive income increased equity by 21,030,001,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rp64.44 Billion | +5.56% |
| Dividends Paid | Rp31.33 Billion | -2.7% |
| Other Comprehensive Income | Rp21.03 Billion | +1.81% |
| Other Changes | Rp-9.29 Billion | -0.8% |
| Total Change | Rp- | 4.02% |
Book Value vs Market Value Analysis
This analysis compares Ekadharma International Tbk's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.55x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.63x to 0.55x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | Rp49.83 | Rp181.00 | x |
| 2013-12-31 | Rp62.75 | Rp181.00 | x |
| 2014-12-31 | Rp71.19 | Rp181.00 | x |
| 2015-12-31 | Rp78.09 | Rp181.00 | x |
| 2016-12-31 | Rp163.24 | Rp181.00 | x |
| 2017-12-31 | Rp183.27 | Rp181.00 | x |
| 2018-12-31 | Rp200.46 | Rp181.00 | x |
| 2019-12-31 | Rp236.33 | Rp181.00 | x |
| 2020-12-31 | Rp264.20 | Rp181.00 | x |
| 2021-12-31 | Rp285.71 | Rp181.00 | x |
| 2022-12-31 | Rp309.37 | Rp181.00 | x |
| 2023-12-31 | Rp318.91 | Rp181.00 | x |
| 2024-12-31 | Rp331.74 | Rp181.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ekadharma International Tbk utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.56%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.15%
- • Asset Turnover: 0.41x
- • Equity Multiplier: 1.12x
- Recent ROE (5.56%) is below the historical average (12.63%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 13.89% | 7.43% | 1.40x | 1.33x | Rp1.71 Billion |
| 2001 | 12.85% | 7.44% | 1.35x | 1.28x | Rp1.32 Billion |
| 2002 | 12.86% | 8.16% | 1.31x | 1.20x | Rp1.39 Billion |
| 2003 | 8.72% | 5.30% | 1.35x | 1.22x | Rp-636.64 Million |
| 2004 | 8.35% | 5.62% | 1.26x | 1.18x | Rp-881.73 Million |
| 2005 | 9.46% | 4.95% | 1.39x | 1.37x | Rp-295.61 Million |
| 2006 | 9.96% | 5.23% | 1.48x | 1.29x | Rp-23.83 Million |
| 2007 | 6.96% | 2.88% | 1.73x | 1.40x | Rp-1.85 Billion |
| 2008 | 7.80% | 2.52% | 1.30x | 2.39x | Rp-1.30 Billion |
| 2009 | 23.65% | 8.01% | 1.24x | 2.38x | Rp9.49 Billion |
| 2010 | 22.99% | 9.63% | 1.24x | 1.92x | Rp13.83 Billion |
| 2011 | 20.29% | 8.03% | 1.38x | 1.83x | Rp13.38 Billion |
| 2012 | 20.66% | 9.34% | 1.41x | 1.57x | Rp18.56 Billion |
| 2013 | 17.72% | 9.28% | 1.22x | 1.57x | Rp16.93 Billion |
| 2014 | 16.19% | 7.65% | 1.28x | 1.66x | Rp15.40 Billion |
| 2015 | 17.28% | 8.87% | 1.36x | 1.43x | Rp19.86 Billion |
| 2016 | 15.40% | 15.44% | 0.81x | 1.23x | Rp30.78 Billion |
| 2017 | 11.77% | 11.71% | 0.81x | 1.24x | Rp11.32 Billion |
| 2018 | 10.33% | 9.78% | 0.87x | 1.22x | Rp2.32 Billion |
| 2019 | 8.93% | 9.73% | 0.78x | 1.17x | Rp-8.80 Billion |
| 2020 | 10.13% | 13.92% | 0.62x | 1.18x | Rp1.19 Billion |
| 2021 | 10.46% | 16.58% | 0.54x | 1.17x | Rp4.59 Billion |
| 2022 | 7.10% | 12.49% | 0.50x | 1.13x | Rp-31.37 Billion |
| 2023 | 6.46% | 13.88% | 0.42x | 1.12x | Rp-39.48 Billion |
| 2024 | 5.56% | 12.15% | 0.41x | 1.12x | Rp-51.47 Billion |
Industry Comparison
This section compares Ekadharma International Tbk's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $1,447,646,425,240
- Average return on equity (ROE) among peers: 8.83%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ekadharma International Tbk (EKAD) | Rp1.21 Trillion | 13.89% | 0.08x | $6.90 Million |
| Avia Avian PT Tbk (AVIA) | $9.92 Trillion | 16.55% | 0.13x | $237.02 Million |
| PT Chemstar Indonesia Tbk (CHEM) | $22.55 Billion | 17.20% | 2.16x | $2.55 Million |
| Colorpak Indonesia Tbk (CLPI) | $506.35 Billion | 8.47% | 0.53x | $8.33 Million |
| Duta Pertiwi Nusantara Tbk (DPNS) | $277.71 Billion | 3.75% | 0.16x | $2.71 Million |
| Lotte Chemical Titan Tbk PT (FPNI) | $-6.78 Billion | 0.00% | 0.00x | $9.60 Million |
| Indo Komoditi Korpora Tbk PT (INCF) | $-7.00 Billion | 0.00% | 0.00x | $1.70 Million |
| Intanwijaya Internasional Tbk (INCI) | $122.94 Billion | 16.33% | 0.23x | $2.63 Million |
| PT Kusuma Kemindo Sentosa Tbk (KKES) | $66.52 Billion | 7.77% | 0.86x | $970.56K |
| Lautan Luas Tbk (LTLS) | $2.13 Trillion | 9.43% | 1.97x | $27.18 Million |